0000313616-24-000002.txt : 20240104 0000313616-24-000002.hdr.sgml : 20240104 20240104170059 ACCESSION NUMBER: 0000313616-24-000002 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240101 FILED AS OF DATE: 20240104 DATE AS OF CHANGE: 20240104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Riley Christopher Paul CENTRAL INDEX KEY: 0002000111 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-08089 FILM NUMBER: 24513013 MAIL ADDRESS: STREET 1: 2200 PENNSYLVANIA AVE NW STREET 2: SUITE 800 W CITY: WASHINGTON STATE: DC ZIP: 20037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DANAHER CORP /DE/ CENTRAL INDEX KEY: 0000313616 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL [3823] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 591995548 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2200 PENNSYLVANIA AVE. N.W. STREET 2: SUITE 800W CITY: WASHINGTON STATE: DC ZIP: 20037-1701 BUSINESS PHONE: 2028280850 MAIL ADDRESS: STREET 1: 2200 PENNSYLVANIA AVE. N.W. STREET 2: SUITE 800W CITY: WASHINGTON STATE: DC ZIP: 20037-1701 FORMER COMPANY: FORMER CONFORMED NAME: DMG INC DATE OF NAME CHANGE: 19850221 3 1 wk-form3_1704405602.xml FORM 3 X0206 3 2024-01-01 0 0000313616 DANAHER CORP /DE/ DHR 0002000111 Riley Christopher Paul 2200 PENNSYLVANIA AVE NW SUITE 800W WASHINGTON DC 20037 0 1 0 0 Executive Vice President Common Stock 13073 D Employee stock option (right to buy) 76.47 2017-02-24 2027-02-24 Common Stock 7801 D Employee stock option (right to buy) 82.10 2017-11-15 2027-11-15 Common Stock 6552 D Employee stock option (right to buy) 88.24 2018-02-24 2028-02-24 Common Stock 13047 D Employee stock option (right to buy) 100.81 2019-02-24 2029-02-24 Common Stock 16537 D Employee stock option (right to buy) 116.41 2019-05-15 2029-05-15 Common Stock 6957 D Employee stock option (right to buy) 139.30 2020-02-24 2030-02-24 Common Stock 14488 D Employee stock option (right to buy) 198.09 2021-02-24 2031-02-24 Common Stock 11145 D Employee stock option (right to buy) 241.22 2022-02-24 2032-02-24 Common Stock 10068 D Employee stock options (right to buy) 241.22 2022-02-24 2032-02-24 Common Stock 8883 D Employee stock option (right to buy) 221.29 2023-02-24 2033-02-24 Common Stock 11298 D Danaher Deferred Compensation Programs - Danaher Stock Fund 0 Common Stock 3738.715 D Date shown is grant date. Twenty percent of the options became or become exercisable on each of the first five anniversaries of the grant date. Date shown is grant date. One third of the options became or become exercisable on each of the third, fourth and fifth anniversaries of the grant date. Date shown is grant date. Twenty-five percent of the options became or become exercisable on each of the first four anniversaries of the grant date. Represents the participant's and/or Company contributions to the Danaher stock fund in the reporting person's account under one or more of the plans that form part of Danaher's deferred compensation program. The contributions are deemed to be invested in a number of unfunded, notional shares of Danaher common stock based on the closing price of Danaher common stock as reported on the NYSE on the date such compensation is credited. The vesting terms and manner and form of distribution of amounts contributed or deferred under the program are based upon the provisions of the respective plan, which provisions are summarized in the latest Danaher Corporation annual meeting proxy statement on Schedule 14A as filed with the Securities and Exchange Commission. The notional shares convert on a one-for-one basis. Exhibit List: Exhibit 24: Power of Attorney /s/ James F. O'Reilly as attorney-in-fact for Christopher Paul Riley 2024-01-04 EX-24 2 rileypoa.htm EX-24 Document
Exhibit 24
POWER OF ATTORNEY
Know all by these presents, that the undersigned hereby constitutes and appoints James F. O’Reilly, signing singly, the undersigned's true and lawful attorney-in-fact to:
(1) execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer and/or director of Danaher Corporation (the “Company”), Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;
(2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any amendment or amendments thereto, and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and
(3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.
The undersigned hereby grants to such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorney-in-fact, in serving in such capacity at the request of the undersigned, is not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.
This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorney-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 14 day of October, 2023.

By: /s/ Chris Riley
Name: Christopher Riley